Position in SNY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$240,730
-$38,521 QoQ
Shares Held
5,643
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#453
of 712 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Patten Group, Inc. holds $22,707,053 across 8 Drug Manufacturers - General names. SNY ranks #8 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
22,927 | $5,822,770 | |
| 2 | AZN |
Astrazeneca PLC
|
29,983 | $5,685,376 | |
| 3 | MRK |
Merck & Co., Inc.
|
26,376 | $3,389,316 | |
| 4 | LLY |
ELI LILLY & Co
|
2,822 | $3,384,791 | |
| 5 | NVS |
Novartis AG
|
16,667 | $2,612,051 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
19,094 | $1,100,195 | |
| 7 | ABBV |
AbbVie Inc.
|
1,875 | $471,824 | |
| 8 | SNY |
Sanofi
This page
|
5,643 | $240,730 |
All Filings in SNY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $240,730 | 5,643 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $279,251 | 5,796 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $282,182 | 5,823 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $533,029 | 11,293 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $565,082 | 11,697 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $647,218 | 11,670 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $587,779 | 12,187 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $972,736 | 16,879 | Shares | Sole | 2024-10-08 | |
| 2024-06-30 | $850,701 | 17,533 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $954,941 | 19,649 | Shares | Sole | 2024-04-17 | |
| 2023-12-31 | $963,518 | 19,375 | Shares | Sole | 2024-01-10 | |
| 2023-09-30 | $847,404 | 15,798 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $849,571 | 15,762 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $865,658 | 15,907 | Shares | Sole | 2023-04-06 | |
| 2022-12-31 | $772,797 | 15,957 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $629,192 | 16,549 | Shares | Sole | 2022-10-13 | |
| 2022-06-30 | $865,619 | 17,302 | Shares | Sole | 2022-07-18 | |
| 2022-03-31 | $878,222 | 17,106 | Shares | Sole | 2022-04-28 | |
| 2021-12-31 | $878,703 | 17,539 | Shares | Sole | 2022-01-20 | |
| 2021-09-30 | $869,804 | 18,042 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $863,887 | 16,405 | Shares | Sole | 2021-08-03 | |
| 2021-03-31 | $769,449 | 15,557 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $537,162 | 11,055 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $504,258 | 10,051 | Shares | Sole | 2020-10-19 | |
| 2020-06-30 | $429,279 | 8,409 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $338,217 | 7,736 | Shares | Sole | 2020-04-16 | |
| No filing history on record for this holder in this stock. | ||||||